MG-132

目录号:S2619

MG-132 Chemical Structure

Molecular Weight(MW): 475.62

MG-132是一种具有细胞透性的蛋白酶体calpain抑制剂,IC50分别为100 nM和1.2 μM。

规格 价格 库存 购买数量  
RMB 411.08 现货
RMB 1395.18 现货
RMB 3841.93 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

Selleck的MG-132蛋白酶体抑制效果显著高于Sigma同类产品,正是因为采用了效果最好的(S,R,S)-(-)-2构型

p21蛋白可以被泛素化降解,MG-132通过抑制蛋白酶体活性导致了p21的累积,因此,MG-132抑制效果越强,p21蛋白累积越多。(检测蛋白:p21; 细胞种类:HeLa细胞系; 处理条件:终浓度5μM,处理时间6h)

客户使用Selleck该产品发表文献54篇:

客户使用该产品的11个实验数据:

  • Western blot of IκBζ expression in BMDMs treated with DI and stimulated with LPS for 1 h. MG132 or bafilomycin A (BafA) were added 30 min before LPS stimulation.

    Nature, 2018, 556(7702):501-504. MG-132 purchased from Selleck.

    MDA-MB-231 cells were treated with 10 uM MG132 and incubated under normoxia or hypoxia for 4 h. Endogenous interaction between LATS2 and SIAH2 was analysed by immunoprecipitation.

    Nat Cell Biol 2015 17(1), 95-103. MG-132 purchased from Selleck.

  • HeLa cells were transfected with control mimic, RMND5A siRNA or miR-138 mimic. After transfection for 36 h, cells were treated with proteasome inhibitor MG132 (20 uM) or Dimethyl sulfoxide (DMSO) for 8 h. Endogenous Exportin-5 protein and RMND5A protein expression was measured by western blotting.

    Nucleic Acids Res 2014 42(1), 458-74. MG-132 purchased from Selleck.

    HeLa cells were transfected with negative control mimic, miR-138 mimic or RMND5A siRNA. After transfection for 36 h, cells were treated with MG132 (20 uM) or DMSO for 8 h. RMND5A and Exportin-5 protein expression were analyzed by immunocytochemistry. Nuclei were counterstained with DAPI.

    Nucleic Acids Res 2014 42(1), 458-74. MG-132 purchased from Selleck.

  •  

    TFEB induced autophagy dependent ATZ clearance in vitro. MEF transiently co-transfected with either ATZ plus GFP expressing plasmids or ATZ plus TFEB expressing plasmids were incubated with proteasome inhibitor MG132 or with DMSO for 6 h. Upon MG132 treatment, steady state levels of 52 kDa ATZ band increased in both cells transfected with ATZ plus GFP and with ATZ plus TFEB expressing plasmids. Quantification of band intensities showed a 48% reduction of ATZ in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP, in the absence of the proteasome inhibitor. In MG132 treated cells, a 61% decrease of ATZ was detected in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP.

    EMBO Mol Med 2013 5, 397-412. MG-132 purchased from Selleck.

    JAK1 expression was analyzed in A375 cells expressing scrambled shRNA or shRNF125 (#2) and treated with MG132 (5 uM, 10 hr), and in Lu1205 cells expressing WT RNF125 and treated with MG132.

    Cell Rep 2015 11(9), 1458-73. MG-132 purchased from Selleck.

  • LRB1 and LRB2 regulate phyB protein levels. PhyB protein levels in crude extracts from the wild type (WT) and the indicated mutant backgrounds were assayed by immunoblot analysis with anti-phyB monoclonal antibodies. Anti-PBA1 and anti-histone H3 antibodies were used to confirm equal protein loading. Rc-induced loss of phyB in the wild type is inhibited by 100 uM MG132.

    Plant Physiol 2012 60(1), 118-34. MG-132 purchased from Selleck.

    Representative images for γ-H2AX-stained cells treated with 100 uM FA for 3 h without or with MG132. Fluorescence was measured in at least 50 nuclei in each of three experiments.

    Toxicol Appl Pharmacol 2015 286(2), 135-41. MG-132 purchased from Selleck.

  • Nek2A impedes SuFu ubiquitination. HEK293T cells transfected with Nek2A-Myc and Flag-SuFu for 48 h were treated with MG-132 to enrich ubiquitinated proteins, and subsequently subjected to co-immunoprecipitation assay. Precipitated proteins were probed using anti-Ub antibody.

    Int J Oncol, 2017, 50(2):373-380. MG-132 purchased from Selleck.

    GSK-3β phosphorylation at Ser9 is enhanced in NOK-overexpressed stable cell lines. The proteasome inhibitor, MG132, was added in medium of HeLa-HA and HeLa-NOK-HA cells for 12 h and then the p-GSK-3b(Ser9) was assayed by western blotting.

    FEBS Lett 2012 586, 3787–3792. MG-132 purchased from Selleck.

  • Truncated mouse Period2 (Per2) protein was expressed in NIH3T3 cells, treated by cycloheximide with or without MG132 for 1-4 hours.Per2 was reported to be degraded by the proteasome proteolysis. By adding MG132 (25 μM), a proteasome inhibitor, the degradation of Per2 was dramatically decreased within 4 hours treatment (shown by western blot).

    2012 Dr. Edison DUKE-NUS Graduate Medical School Singapore.. MG-132 purchased from Selleck.

质量管理及产品安全说明书

Proteasome抑制剂选择性比较

生物活性

产品描述 MG-132是一种具有细胞透性的蛋白酶体calpain抑制剂,IC50分别为100 nM和1.2 μM。
靶点
20S proteasome [9]
(Cell-free assay)
100 nM
体外研究

MG-132抑制20S 蛋白酶体ZLLL-MCA降解活性,IC50为100 nM,比ZLLal(IC50为110 μM)有效1000多倍。MG-132也会抑制钙蛋白酶,IC50 为1.2 μM。MG-132在20 nM的最佳浓度下诱导PC12细胞中神经突增生,表现出高于ZLLal 500倍的效能。[1] MG-132 (10 μM) 通过抑制蛋白酶体介导的IκBα降解,有效抑制A549细胞中TNF-α诱导的NF-κB活化,白介素-8 (IL-8)基因转录,和IL-8蛋白质释放。[2] MG-132处理通过抑制26S蛋白酶体,有效诱导p53依赖性KIM-2细胞凋亡。[3]不同于BzLLLCOCHO或PS-341,MG-132处理对26S蛋白酶体的糜蛋白样(CT-L)和肽谷氨酰基肽水解(PGPH)活性抑制较弱,而相对于BzLLLCOCHO,MG-132能够更有效诱导多发性骨髓瘤细胞(U266 和OPM-2)的细胞凋亡。[4] MG-132 (1 μM)通过激活AP-1家族成员c-Fos和 c-Jun,使TRAIL抗性前列腺癌细胞敏感,这反过来抑制抗凋亡分子c-FLIP(L)。[5] MG-132显著增强肌醇六磷酸(IP6) 的作用以降低PC3 和DU145雄激素非依赖性前列腺癌(AIPCa)细胞系的细胞代谢活性。[6]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
LPS-stimulated RAW264.7 cells MojESpVv[3Srb36gRZN{[Xl? M2TYRVI2KM7:TR?= NGDDbZNFVVOR MlHJTY5pcWKrdIOgcol1emmlIH;4bYRmKHC{b3T1Z5Rqd25id3n0bEBKSzVyIH;mJFAvOSEQvF2= NEXYd4YzPDZ7N{S5Oi=>
HL-60 Mn7HR5l1d3SxeHnjJGF{e2G7 NInsUW41OCEQvF2= NV3mO5EyPDhiaB?= MVfEUXNQ MkK5TWM2ODxzMDFOwG0> NGnRbWYzPDZ7N{S5Oi=>
SMMC-7721 M2PhO2N6fG:2b4jpZ{BCe3OjeR?= MUW0NEDPxE1? NF7EPI01QCCq MoLZSG1UVw>? NXP3V4pOUUN3ME23MlEh|ryP MUSyOFY6PzR7Nh?=
A-549 MlnGR5l1d3SxeHnjJGF{e2G7 M2XCb|QxKM7:TR?= NI\UNlk1QCCq NWP6WY1GTE2VTx?= NEjVSZdKSzVyPEGwJO69VQ>? MljyNlQ3QTd2OU[=
MCF-7 NF\2R|NEgXSxdH;4bYMhSXO|YYm= MVm0NEDPxE1? M{fPXlQ5KGh? NGrqS2tFVVOR NX3EcYdCUUN3ME23MlMh|ryP MnLRNlQ3QTd2OU[=
SW-480 NEXnb3BEgXSxdH;4bYMhSXO|YYm= MXS0NEDPxE1? NIXQbGY1QCCq MYDEUXNQ Mn3wTWM2OD12IN88US=> Ml;MNlQ3QTd2OU[=
NCI-H929 MkTXR5l1d3SxeHnjJGF{e2G7 MXuxJO69VQ>? M3zIUlczKGh? MUnEUXNQ NGDFO4RKSzVyPUCuNVch|ryP NFTDXIwzPDZ{NUC4PC=>
293T NUjN[ZI3S3m2b4TvfIlkKEG|c3H5 NEWzXXQyOCEQvF2= MWe3NkBp NVHC[IFJTE2VTx?= M37L[GlEPTB:MjFOwG0> NH36VlAzPDZ{NUC4PC=>
293T NGLnNnRHfW6ldHnvckBCe3OjeR?= NEHTPYMyOCEQvF2= M2Dlb|I1KGh? NGTibHFFVVOR M{D0OG1w\GW{YYTlcJkhcW6mdXPld{Bp\WG2LYPoc4NsKCB? MkjsNlQ3OjVyOEi=
HeLa NWTzPFg5U2mwYYPlJGF{e2G7 NX3HXpRQOTBizszN NEDGfpQyKGh? MlzZSG1UVw>? MknJTY5lfWOnczDQRXJRKGOuZXH2ZYdmKGK7IHnubIljcXSrbnegdJJwe2Wjc3;t[UBi[3Srdnn0fS=> NHvZT|czPDN{MUizNy=>
MDA-MB-231 MmfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M37MW|Eh|ryP NYHRbZo{PzJiaB?= NHvRSItFVVOR MkjUTWM2OD1yLkG4JO69VQ>? NX7rSpJ{OjRzNUOyNFY>
MCF-7 MonpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUn2SFNsOSEQvF2= M4H4[|czKGh? MorMSG1UVw>? M3HncmlEPTB;MD6xN{DPxE1? NVfrSXVuOjRzNUOyNFY>
MCF10A MorhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF\4O4MyKM7:TR?= NFjIVG44OiCq NEnqbmRFVVOR NXvM[m5UUUN3ME2wMlI6KM7:TR?= MUiyOFE2OzJyNh?=
HEK-293 MVzLbY5ie2ViQYPzZZk> M1TiXlIh[W6mIEKwJO69VQ>? NHzkW48zKGh? MknySG1UVw>? MlOxTY5pcWKrdIOgR4hVNUxiYXP0bZZqfHlid3n0bEBKSzVyIH;mJFkhdk1i M1zYPVI{PTRyN{mw
Calu6 MmGwSpVv[3Srb36gRZN{[Xl? NEf3ZZkyOCEQvF2= NXPPTW01OThiaB?= MWHEUXNQ NYf5N4s4W2mpbnnmbYNidnSueTDhZ4N2dXWuYYTld{BnemG2YYjpckBxemWldYLzc5I> MWOyN|UxPjR6Nh?=
IFN-gamma-induced RAW264.7 MYrGeY5kfGmxbjDBd5NigQ>? MkLESG1UVw>? NGP5TIxKdmirYnn0d{BvcXS{aXOgc5hq\GVicILv[JVkfGmxbjD3bZRpKEmFNUCgc4YhOC5yN{eg{txO MXOyNlI4PzJ5Nx?=
IPC227F M3zxUmN6fG:2b4jpZ{BCe3OjeR?= NWWzSo9EOSEQvF2= NX3qPYZJPDhiaB?= MVLEUXNQ MX\JR|UxRTBwMEe3JO69VQ>? NXzodoRFOjF7MkS1Nlg>
Hepa-1c1c7 NV7QboVrTnWwY4Tpc44hSXO|YYm= MmnwNlUh|ryP MnzsOkBp NIjFfFJFVVOR NH\nS3NKdmO{ZXHz[ZMhVnKoMjDwdo91\WmwIHzleoVt MnX6NlA{QTJ3NES=
COS-7 NEK5b29EgXSxdH;4bYMhSXO|YYm= MVGxNEDPxE1? M4rBOWROW09? MXPJR|UxRDFyIN88US=> M2\RZVE5ODh6MEm3
HuH-7 NYjtS4hTS3m2b4TvfIlkKEG|c3H5 NYXHe3E6OTBizszN NX\keGJuTE2VTx?= MlnCTWM2ODxzMDFOwG0> M13rTlE5ODh6MEm3
OCI-Ly3 NGKydoRHfW6ldHnvckBCe3OjeR?= MoXaNVAh|ryPwrC= NIXqNI41KGh? M2ntXmROW09? MkSzTY5lfWOnczDoeY1idiCLa3HwdIFD[WyyaHGgd5Ri[mmuaYrheIlwdiC5aYToJGVEPTBib3[gNUDPxE1? M33kbFE5ODJ2MUGz
A2780 cDDP NWWxXVhYSXCxcITvd4l{KEG|c3H5 MlPSNlQhcA>? M1vLUmROW09? NU\GeGVqUW6mdXPld{BieG:ydH;zbZMh[nliaX7obYJqfGmwZzDQWGVPKGSnZ4Lh[IF1cW:w M1\5U|E4Pjh2MEG4
LPS-stimulated RAW264.7 cells Mn3WSpVv[3Srb36gRZN{[Xl? M4nwUWROW09? NED0UVdKdmirYnn0d{BPTi2tYYDwZWIhTE6DIHLpcoRqdmd? NF7OPZMyPzRyN{K3Oy=>
PC12 MorPSpVv[3Srb36gRZN{[Xl? NF3Kd3MyODBizszNxsA> M2fmZVI1KGh? MlX3SG1UVw>? NFXiUJNKdmirYnn0d{A3NU:KRFGtJIFv\CCKMl:yMYlv\HWlZXSgZ5l1d3SxeHnjbZR6 M2TuSFE4OTV6NEW0
PC3 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXWyNEDPxE1? MVG0PEBp MonNSG1UVw>? NXnxRYNbUUN3ME2wMlYh|ryP M{XDPVE3Pjh4NUO3
LP-1 M4roZWFxd3C2b4Ppd{BCe3OjeR?= MkS0N|AxKG6P MYeyOEBp MWfEUXNQ Mk\MTY5lfWOnczDhdI9xfG:|aYOgZpkhcW6lcnXhd4lv\yClbHXheoVlKFCDUmCgcIV3\WxiYX7kJJJm\HWlaX7nJG1kdC1zIIDyc5RmcW5ibHX2[Yw> MoC4NVU6PTh3OEm=
ES6 Mk\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV\zWIVHUUN3ME2wMlAyOzB4IN88US=> NVXXfIFXW0GQR1XS
A101D MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlrFTWM2OD1yLkCzNlc6KM7:TR?= M1nDZnNCVkeHUh?=
OCUB-M NYnCWHBRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWXJR|UxRTBwMEO3N|ch|ryP MU\TRW5ITVJ?
LB2518-MEL Mki5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2\wUmlEPTB;MD6wN|c3KM7:TR?= MVrTRW5ITVJ?
SH-4 MmqwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTuV2ZRUUN3ME2wMlA1OzFizszN M3e5[3NCVkeHUh?=
KNS-42 M1vE[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXPJR|UxRTBwMES0OFEh|ryP NHm0SoNUSU6JRWK=
DSH1 M{LyVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVvJR|UxRTBwMEWyPFkh|ryP MXvTRW5ITVJ?
NTERA-S-cl-D1 M{HNeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRTBwMEW3O|Ih|ryP MVLTRW5ITVJ?
D-542MG M1TGbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVHJR|UxRTBwMEW5OVch|ryP NWrIT4NTW0GQR1XS
KS-1 NXvtb2dyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH6xbZRKSzVyPUCuNFY1PThizszN NFrYb4xUSU6JRWK=
BL-41 NY\3NZYyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVXJR|UxRTBwME[5OFch|ryP MWfTRW5ITVJ?
LXF-289 NH:5NnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3P6R2lEPTB;MD6wO|A3PiEQvF2= NYDJfmwzW0GQR1XS
D-247MG MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWr3[ZF7UUN3ME2wMlA4OjB7IN88US=> M2LGSnNCVkeHUh?=
MMAC-SF Mm\SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIXDPYVKSzVyPUCuNFczPjhizszN M2T0[3NCVkeHUh?=
CP66-MEL M2r4TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHnscXJKSzVyPUCuNFc2KM7:TR?= MYfTRW5ITVJ?
LB771-HNC NWHvfGtTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGDaNnlKSzVyPUCuNFgxOzZizszN MXjTRW5ITVJ?
no-10 NEnVTVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVLSRWtTUUN3ME2wMlA5QTB7IN88US=> MV\TRW5ITVJ?
A388 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\yV4tKSzVyPUCuNFkxPjVizszN MmLWV2FPT0WU
OPM-2 NF\kcoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXLJR|UxRTBwMUC0O|Qh|ryP M{jVTHNCVkeHUh?=
OVCAR-4 NVrH[FVUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHrsZ|RKSzVyPUCuNVA6OzhizszN NFzD[o9USU6JRWK=
HOP-62 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUDJR|UxRTBwMUC5OFkh|ryP M1vxSnNCVkeHUh?=
ML-2 NVXZUVVyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXHuPJB{UUN3ME2wMlEyQDB4IN88US=> Mnr4V2FPT0WU
UACC-257 NWrISZNET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVz2PI5iUUN3ME2wMlEyQTJ5IN88US=> M{L1V3NCVkeHUh?=
NEC8 MmTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGq1T3NKSzVyPUCuNVE6QTVizszN NFKzdldUSU6JRWK=
ONS-76 M1PSe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF6xSpFKSzVyPUCuNVI6OzVizszN MUPTRW5ITVJ?
KE-37 MkjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmXUTWM2OD1yLkGzNlc5KM7:TR?= MkLmV2FPT0WU
HT-144 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHHTT3ZKSzVyPUCuNVM5QTVizszN NIHWXVZUSU6JRWK=
LB2241-RCC NEDiVlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUTJR|UxRTBwMUSyOFch|ryP MlzlV2FPT0WU
TE-5 Mly4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mnv2TWM2OD1yLkG0Nlc5KM7:TR?= M2XIcnNCVkeHUh?=
KINGS-1 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkTsTWM2OD1yLkG0O|kh|ryP NUnpTmU2W0GQR1XS
NCI-H69 NH3XPGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1vHZmlEPTB;MD6xOVE1OSEQvF2= MVLTRW5ITVJ?
CAS-1 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlT1TWM2OD1yLkG1OFgzKM7:TR?= MWPTRW5ITVJ?
D-263MG NYrLNmdST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXzJR|UxRTBwMU[wNFYh|ryP M3LkPXNCVkeHUh?=
A253 NHPJZ|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mnf5TWM2OD1yLkG2NVI5KM7:TR?= MYLTRW5ITVJ?
PF-382 NFPVb5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnH1TWM2OD1yLkG2O|A3KM7:TR?= MoTsV2FPT0WU
CESS NEC5PYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmLoTWM2OD1yLkG3NFYh|ryP Mln3V2FPT0WU
MZ2-MEL NIqzR4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV;JR|UxRTBwMUe1OVkh|ryP NWnOeo9TW0GQR1XS
HEL NH3JWY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkLaTWM2OD1yLkG4OVE4KM7:TR?= MmPtV2FPT0WU
D-392MG MorZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mly3TWM2OD1yLkG5NVE2KM7:TR?= NYi4VZY2W0GQR1XS
SK-LMS-1 M{\GW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnvUTWM2OD1yLkG5N|A{KM7:TR?= NIfnN4ZUSU6JRWK=
GI-ME-N M17JWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoHhTWM2OD1yLkG5N|A3KM7:TR?= NWfxTFA{W0GQR1XS
LB831-BLC NWf4[oFUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NETvd2hKSzVyPUCuNVk{PCEQvF2= Mnn2V2FPT0WU
DU-4475 NVPu[YF4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUPJR|UxRTBwMUm2OVgh|ryP MV7TRW5ITVJ?
IST-SL1 M1zSc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWXJR|UxRTBwMkCwPVQh|ryP NXXwT3FmW0GQR1XS
GAK MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\hOXpKSzVyPUCuNlA2OzRizszN NF;LU4NUSU6JRWK=
EW-1 MnfXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NILqcnJKSzVyPUCuNlExPDdizszN MYLTRW5ITVJ?
LAMA-84 M3vPNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYHJR|UxRTBwMkG4OVEh|ryP M1:wU3NCVkeHUh?=
SK-UT-1 MonDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUTJR|UxRTBwMkKwOFkh|ryP NGK4WppUSU6JRWK=
VA-ES-BJ M{DET2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTBwMkKyOVch|ryP Mn3jV2FPT0WU
ACN NWHsZVZFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkjITWM2OD1yLkKyOlM5KM7:TR?= Mlr2V2FPT0WU
SK-PN-DW MkXmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVPjflU6UUN3ME2wMlI{OTlizszN NITQb4VUSU6JRWK=
HD-MY-Z MkflS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{PPTWlEPTB;MD6yN|MxOyEQvF2= M2j6bHNCVkeHUh?=
LB373-MEL-D NWK4OZQ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXnJR|UxRTBwMkSxPVgh|ryP NX7rNWNVW0GQR1XS
COLO-829 NHPPU3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX;JR|UxRTBwMkSyOVch|ryP MmnCV2FPT0WU
ES8 NYHQbnZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVTJR|UxRTBwMkS3OlMh|ryP MoHsV2FPT0WU
RXF393 NF\SeJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmK0TWM2OD1yLkK1NFE2KM7:TR?= MnTuV2FPT0WU
TK10 NV3FWlF2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWLPeo8{UUN3ME2wMlI2PDN3IN88US=> MoDKV2FPT0WU
LOUCY NV;lNnhsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlnsTWM2OD1yLkK1OFU3KM7:TR?= MV;TRW5ITVJ?
MZ7-mel NFPle|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnroTWM2OD1yLkK2N|c1KM7:TR?= MmToV2FPT0WU
CP67-MEL NVrkfmxVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnXVTWM2OD1yLkK2O|Mh|ryP MVXTRW5ITVJ?
C2BBe1 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWTBZYVRUUN3ME2wMlI4QTB5IN88US=> NXHGcnZFW0GQR1XS
K052 M4HZXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmPyTWM2OD1yLkK4PVkh|ryP MnrVV2FPT0WU
MOLT-16 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXHlT416UUN3ME2wMlI6PTJ2IN88US=> MV7TRW5ITVJ?
KNS-81-FD Mnn6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MorWTWM2OD1yLkOwN|I{KM7:TR?= M4XaOnNCVkeHUh?=
CMK NFLDfVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVzJR|UxRTBwM{GxNkDPxE1? NX6zTVhGW0GQR1XS
LAN-6 M1LtcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVTJR|UxRTBwM{GzJO69VQ>? M3T5NHNCVkeHUh?=
KLE NFfyU|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEjLbWRKSzVyPUCuN|E{ODZizszN M3LCfXNCVkeHUh?=
NCCIT M4\2[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3rnVWlEPTB;MD6zNVc5OyEQvF2= NELHeotUSU6JRWK=
HH M17Hcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYHYVFFFUUN3ME2wMlMzQDl5IN88US=> MmnsV2FPT0WU
TE-8 NUTKTHNWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoezTWM2OD1yLkO0Nlc6KM7:TR?= MXPTRW5ITVJ?
GDM-1 NEXITpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXvJR|UxRTBwM{WxNFQh|ryP MoCxV2FPT0WU
NCI-H747 M1Llbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NITl[ppKSzVyPUCuN|cyODNizszN NYTDSYtXW0GQR1XS
NCI-H1092 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV\0bYtQUUN3ME2wMlM5QDR2IN88US=> M4j3OHNCVkeHUh?=
8-MG-BA MkL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnzyTWM2OD1yLkO5PFM4KM7:TR?= NFqwT4lUSU6JRWK=
NB17 MlftS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1vrcWlEPTB;MD60Nlk4KM7:TR?= NXXPcVl1W0GQR1XS
LC4-1 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH7IfG5KSzVyPUCuOFM3ODdizszN MoW4V2FPT0WU
TE-1 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVvqSIFFUUN3ME2wMlQ2OTF7IN88US=> NYnsPW5FW0GQR1XS
KALS-1 M2O1[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MojMTWM2OD1yLkS2OVg1KM7:TR?= Mm\HV2FPT0WU
CCRF-CEM Ml\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{nab2lEPTB;MD60O|Y4PCEQvF2= MUTTRW5ITVJ?
OS-RC-2 NVzGc5MzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXHJR|UxRTBwNEe5O|Ih|ryP M4f0NnNCVkeHUh?=
A704 MkDvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3vWcWlEPTB;MD60PFY6OiEQvF2= Mk\DV2FPT0WU
BB49-HNC NGi1U25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYHJR|UxRTBwNEmwPVYh|ryP M2frXXNCVkeHUh?=
EVSA-T NIrSeIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlLETWM2OD1yLkS5PVEyKM7:TR?= MonIV2FPT0WU
Mo-T M17k[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3v1d2lEPTB;MD61NVc3OiEQvF2= NWHZelFyW0GQR1XS
MONO-MAC-6 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\mUpJKSzVyPUCuOVM3OTFizszN NH7FXmZUSU6JRWK=
BB65-RCC NVnudpo3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUnJR|UxRTBwNU[4NVEh|ryP M2XUe3NCVkeHUh?=
NCI-H1882 NGKxUYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVXJR|UxRTBwNUmwN|Yh|ryP MkWxV2FPT0WU
TE-9 M3u0T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV3JR|UxRTBwNkGwN|Mh|ryP M13DdXNCVkeHUh?=
NCI-H2126 MmTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkPkTWM2OD1yLk[yOlY6KM7:TR?= M{PPbHNCVkeHUh?=
SF268 M4nMSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHu5OWtKSzVyPUCuOlU3PDFizszN Mnm2V2FPT0WU
SW872 M2TnR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfpTWM2OD1yLk[1O|I6KM7:TR?= MXzTRW5ITVJ?
LS-513 NGqyOINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlS5TWM2OD1yLk[2O|UyKM7:TR?= M3HJbHNCVkeHUh?=
NCI-H1355 NUK2THo{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1fPdmlEPTB;MD62PFYyQSEQvF2= M{j2WXNCVkeHUh?=
BL-70 M4D4WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1TVbGlEPTB;MD62PVM5QCEQvF2= M4jOXnNCVkeHUh?=
NCI-SNU-5 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVv5NG1CUUN3ME2wMlY6PTR3IN88US=> NIjEcJlUSU6JRWK=
SNU-C2B MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYDJR|UxRTBwN{C3N|kh|ryP NUi4e3htW0GQR1XS
GB-1 M4fSVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV3wZlE2UUN3ME2wMlczOTJ2IN88US=> MVnTRW5ITVJ?
CTB-1 NGXK[VdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkK1TWM2OD1yLke3PVU2KM7:TR?= M4H6TXNCVkeHUh?=
Becker NEflZlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn\uTWM2OD1yLke5OlIyKM7:TR?= MlLRV2FPT0WU
KM12 NGLSSHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWfleoZkUUN3ME2wMlg2PDZ4IN88US=> MYjTRW5ITVJ?
ES7 M1[3c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmrXTWM2OD1yLki5OlUh|ryP NWT1Wop{W0GQR1XS
COLO-684 Mm\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVu0SpdsUUN3ME2wMlkxPjV6IN88US=> NVrQdoxrW0GQR1XS
HCC2998 Ml;QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU\JR|UxRTBwOUO4OVQh|ryP NWrHXYxzW0GQR1XS
TE-10 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MW\JR|UxRTBwOU[0N{DPxE1? Ml7vV2FPT0WU
SF126 Mn:wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1T3O2lEPTB;MD65PFk4OSEQvF2= MXfTRW5ITVJ?
EKVX M130emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1zBR2lEPTB;MT6wN|Q1OiEQvF2= MVfTRW5ITVJ?
KARPAS-45 MkDFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NE\XbY1KSzVyPUGuNFQxOTZizszN NUPpWVVFW0GQR1XS
KGN NGjHeYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NULFOldqUUN3ME2xMlA2ODR3IN88US=> NXLUU3l1W0GQR1XS
ES1 MnXES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEnEbVJKSzVyPUGuNFc6OjFizszN MXzTRW5ITVJ?
L-540 Mlu5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnLFTWM2OD1zLkGxPFM6KM7:TR?= MmLOV2FPT0WU
KURAMOCHI MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILvTppKSzVyPUGuNVI{PzRizszN MXLTRW5ITVJ?
LU-65 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlT5TWM2OD1zLkGyO|U{KM7:TR?= NVv3epVjW0GQR1XS
MFH-ino MmT1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoTnTWM2OD1zLkG3OVAyKM7:TR?= MlPZV2FPT0WU
NCI-H23 NWXMcpR4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mom2TWM2OD1zLkKwOFEh|ryP NF;kSXFUSU6JRWK=
IA-LM MmLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYrLWWJoUUN3ME2xMlI1OTF4IN88US=> Mn2zV2FPT0WU
PSN1 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUHlOFBKUUN3ME2xMlI4ODF4IN88US=> M3rmPXNCVkeHUh?=
NCI-H719 NGDOZ2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHnCRVhKSzVyPUGuNlc1OTFizszN MmfKV2FPT0WU
SW684 NXX3RolRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVXJR|UxRTFwMki2OVkh|ryP NHW3SoVUSU6JRWK=
HCE-4 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXX3N3J{UUN3ME2xMlMxOjJzIN88US=> MoD3V2FPT0WU
EW-16 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\mc3dKSzVyPUGuN|E{PDdizszN M4f1bnNCVkeHUh?=
NCI-H128 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGrhe2hKSzVyPUGuN|U5OTRizszN M{XpO3NCVkeHUh?=
HC-1 NY\XTW5xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3;yNWlEPTB;MT6zPFE4KM7:TR?= Ml3LV2FPT0WU
IST-MES1 MoLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXnpd4F[UUN3ME2xMlQxOjB6IN88US=> Mny5V2FPT0WU
Raji MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfPSnBuUUN3ME2xMlQyQDVizszN NXzze5h4W0GQR1XS
DMS-114 M4TIR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3T6e2lEPTB;MT60OFU{QSEQvF2= MXvTRW5ITVJ?
GI-1 NWDLSFZvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkLuTWM2OD1zLkS3NVMyKM7:TR?= M{OzWHNCVkeHUh?=
NCI-H2081 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWHJR|UxRTFwNUWxPVYh|ryP MWXTRW5ITVJ?
LC-1F NIKye21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{frPGlEPTB;MT61OVE6QCEQvF2= NIjUV2pUSU6JRWK=
NCI-H2227 M1\Obmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2TuRWlEPTB;MT62NVU3OSEQvF2= MnL6V2FPT0WU
D-502MG M4O5OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVviXI1HUUN3ME2xMlY4OjFzIN88US=> NIjRbo1USU6JRWK=
NCI-H2141 MkfsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MknpTWM2OD1zLk[3N|E4KM7:TR?= NXi2S2xDW0GQR1XS
LS-411N NGPtUnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWHJR|UxRTFwNkm4NFch|ryP MVjTRW5ITVJ?
SU-DHL-1 MlLsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXITWM2OD1zLkexNlgyKM7:TR?= NGW3TmFUSU6JRWK=
BB30-HNC NFXONlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX20S2ZLUUN3ME2xMlczPjh3IN88US=> M2HaNHNCVkeHUh?=
TE-15 M{XBN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH;mZXJKSzVyPUGuPVI{PzNizszN M4m3dnNCVkeHUh?=
JVM-3 NGDucIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkHmTWM2OD1zLkmzPVA1KM7:TR?= MVLTRW5ITVJ?
IST-SL2 NEPBdIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnfUTWM2OD1{LkCxNlUzKM7:TR?= MkjqV2FPT0WU
EW-18 M2fXd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVLJR|UxRTJwMEKzN|ch|ryP MmCzV2FPT0WU
DJM-1 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFywSHlKSzVyPUKuNFI2PTJizszN MkjxV2FPT0WU
no-11 MkHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2Pz[GlEPTB;Mj6wN|ExPCEQvF2= MUnTRW5ITVJ?
QIMR-WIL NYj5bWFqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXzJR|UxRTJwMU[3OlIh|ryP NWLWWnhuW0GQR1XS
MC-CAR NYnOdW1qT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2\i[mlEPTB;Mj6yNlk2KM7:TR?= Mof4V2FPT0WU
KM-H2 NY\GTnp{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUfJR|UxRTJwMkmwOFMh|ryP MnnQV2FPT0WU
ECC12 MlPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYHJR|UxRTJwM{e5OEDPxE1? MVvTRW5ITVJ?
HCE-T MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVXJR|UxRTJwNES4PFMh|ryP MUHTRW5ITVJ?
MFM-223 NYLQc3JsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2nFRWlEPTB;Mj61NFg4OSEQvF2= MYDTRW5ITVJ?
SW982 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWPjcWQ2UUN3ME2yMlUyPDhizszN MkT1V2FPT0WU
KG-1 M3rPVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH3nbGVKSzVyPUKuPFg4QTFizszN M4fWOXNCVkeHUh?=
ES4 NEPFd3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUnyXIRVUUN3ME2zMlA3OTFzIN88US=> MWLTRW5ITVJ?
SCC-3 M1ThPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV63b4VkUUN3ME2zMlExQDR6IN88US=> MmLMV2FPT0WU
RH-1 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUPJR|UxRTNwM{i3OFgh|ryP NUHZN3M5W0GQR1XS
NCI-H748 NV\GR3V[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIHSeVhKSzVyPUOuOFQzPjZizszN MY\TRW5ITVJ?
HCC2218 M13XWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1jjSWlEPTB;Mz60Olk{PyEQvF2= NIPnO4tUSU6JRWK=
MEG-01 NVvsXZV5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFK2[3VKSzVyPUOuOVk3QCEQvF2= NIjySVNUSU6JRWK=
NB12 Mk\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYDJR|UxRTNwNUm4PFgh|ryP M{DLTnNCVkeHUh?=
SNB75 M1zTS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEL5[mxKSzVyPUOuOlAyODNizszN NFj5VWRUSU6JRWK=
KMS-12-PE MofkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWPJR|UxRTNwNke3NlMh|ryP NH\4bGFUSU6JRWK=
SKM-1 NGPtS2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYrrR2dLUUN3ME2zMlcyOzd4IN88US=> NF\sOldUSU6JRWK=
COLO-320-HSR NUXSNJdWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MknwTWM2OD1|Lke1OlM1KM7:TR?= NUTQZoZSW0GQR1XS
NKM-1 NUntXXFjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGnBfm5KSzVyPUOuO|c{PzhizszN NV\ZOWttW0GQR1XS
TE-6 NFzxfHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX64TZhOUUN3ME2zMlk1PTZzIN88US=> NGHpN2JUSU6JRWK=
D-336MG M3XsUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYXnOpJsUUN3ME20MlAyOTZ4IN88US=> MoG3V2FPT0WU
NCI-H1650 MorzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUDJR|UxRTRwMUW3PVch|ryP MYTTRW5ITVJ?
ES3 NUH3NIhGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEHuV|hKSzVyPUSuN|I5OjRizszN M1[x[HNCVkeHUh?=
YT NHz3OVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NU[xc|l2UUN3ME20MlM2PDJ2IN88US=> MnjiV2FPT0WU
ES5 NX7aVFhiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWDqfm9yUUN3ME20MlQxOjV3IN88US=> NXfhT|ZxW0GQR1XS
LB647-SCLC NX2wdlhrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYPJR|UxRTRwNU[zNFgh|ryP MWLTRW5ITVJ?
HAL-01 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYjJR|UxRTRwNUewN|Qh|ryP NVzwbnNyW0GQR1XS
LP-1 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2i1UWlEPTB;ND63NlM4OSEQvF2= M{PzbnNCVkeHUh?=
BC-1 Mkm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmrUTWM2OD13LkCwOFQ4KM7:TR?= MmmzV2FPT0WU
EB-3 MoW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGDBSpRKSzVyPUWuNFMxPDFizszN M2H3b3NCVkeHUh?=
GT3TKB MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2K2XGlEPTB;NT6xO|Y3OiEQvF2= NF7Ld4xUSU6JRWK=
NCI-H209 NIPodFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1ziNWlEPTB;NT6xPVM2OiEQvF2= NF[xWnlUSU6JRWK=
BT-474 M4jnUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVzJR|UxRTVwMkOxNFIh|ryP M2HIWXNCVkeHUh?=
RKO MojmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{DDUGlEPTB;NT6yN|QzOiEQvF2= MlvVV2FPT0WU
SIMA NID4RndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MknWTWM2OD13LkOwO|Y2KM7:TR?= M1vNUHNCVkeHUh?=
RL M2\4eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV3JR|UxRTVwM{e1OFEh|ryP NFzIW3dUSU6JRWK=
GCIY NWKxTlRMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4TO[WlEPTB;NT60O|I{PiEQvF2= MX;TRW5ITVJ?
Calu-6 M4HUb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlSzTWM2OD13Lk[yNkDPxE1? NH3UcIlUSU6JRWK=
ALL-PO M2PMZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVfsenlZUUN3ME21MlY{Pzl3IN88US=> NV\XflBWW0GQR1XS
ARH-77 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFW1OpdKSzVyPUWuOlcxQDdizszN MX3TRW5ITVJ?
A4-Fuk NVvOUJNVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn;QTWM2OD14LkC4NVE5KM7:TR?= NIrwcmNUSU6JRWK=
NCI-H1581 M2fFdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHz1TJBKSzVyPU[uNlM5PDlizszN NGXlfI9USU6JRWK=
HUTU-80 M1nyV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoryTWM2OD14LkO2PFk4KM7:TR?= NUPZZ4RtW0GQR1XS
TGW NF3DOpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MluzTWM2OD14LkS1OVk{KM7:TR?= MnPlV2FPT0WU
SK-N-FI MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXHJR|UxRTZwNEW4OVQh|ryP NWLQbIxDW0GQR1XS
U-266 MlLsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{K3emlEPTB;Nj61NVkzPiEQvF2= NFvyTFNUSU6JRWK=
EM-2 NXXFTphOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlrJTWM2OD14Lk[3NFk6KM7:TR?= NWrGVIxEW0GQR1XS
NMC-G1 NGPIXHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\tRmNKSzVyPU[uO|E5QTVizszN MX7TRW5ITVJ?
KASUMI-1 NX7Q[JZVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{XsSmlEPTB;Nj64OFc5PyEQvF2= NGfqOGFUSU6JRWK=
NALM-6 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXrX[4ZmUUN3ME22Mlg3PzV2IN88US=> NVvzcY5MW0GQR1XS
OCI-AML2 NGn0NHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETtPZRKSzVyPUeuNFA{OjZizszN MXXTRW5ITVJ?
SHP-77 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2juTmlEPTB;Nz6yNlQ{KM7:TR?= NX7jTXJ[W0GQR1XS
NOMO-1 NWLhTGVQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2K3XmlEPTB;Nz6yOFI2PCEQvF2= MWnTRW5ITVJ?
SK-N-DZ MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEHxToNKSzVyPUeuO|ExQDlizszN MYTTRW5ITVJ?
LB1047-RCC M{juXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{e0bGlEPTB;Nz63NlI{OSEQvF2= NETrT4pUSU6JRWK=
MZ1-PC NWXNTHBJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXLJR|UxRTdwOE[1OVgh|ryP MUHTRW5ITVJ?
NB10 NHrFWJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTdwOUm1OVYh|ryP MU\TRW5ITVJ?
RL95-2 NHXEVYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWDJR|UxRThwMUC4OFIh|ryP Ml34V2FPT0WU
OMC-1 M1PEZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVnmS2xNUUN3ME24MlUzOTlzIN88US=> NIPKfG9USU6JRWK=
D-283MED NInT[FhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XGe2lEPTB;OD65NVcyQSEQvF2= NWW0NXJCW0GQR1XS
MC116 NYTBUHB1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGLuO2dKSzVyPUiuPVc6PCEQvF2= NIPHe2RUSU6JRWK=
SJSA-1 NXjGUpEzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIL3OWRKSzVyPUmuNFkxQTFizszN M{jWd3NCVkeHUh?=
JiyoyeP-2003 M1Hk[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFyxSHJKSzVyPUmuNlk{OTdizszN MVzTRW5ITVJ?
IST-MEL1 NHjwT|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFzpVIVKSzVyPUmuO|QyQThizszN NWPSdJM1W0GQR1XS
CTV-1 NWnS[Vl2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH;hVGVKSzVyPUGwMlA6PzlizszN NXnvUmtJW0GQR1XS
NH-12 NYDrW4tiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoDQTWM2OD1zMD6yOFM{KM7:TR?= NGX1N4dUSU6JRWK=
CA46 MkfmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mor3TWM2OD1zMD6zOlEh|ryP MVTTRW5ITVJ?
NCI-SNU-1 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX3JR|UxRTFyLkS5Olkh|ryP MlrDV2FPT0WU
SCLC-21H NXHH[YhPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH3YdlVKSzVyPUGwMlY2QTZizszN NWT3ZWtYW0GQR1XS
EC-GI-10 M3zXSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{j0RWlEPTB;MUCuO|A{OSEQvF2= MYLTRW5ITVJ?
SR NIq1NlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTFzLkCxPFUh|ryP M{\iU3NCVkeHUh?=
NCI-H1648 MkD3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFXXXIdKSzVyPUGxMlA6PjVizszN MXPTRW5ITVJ?
TGBC1TKB NGrX[lVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXPvSZI2UUN3ME2xNU41OTB{IN88US=> NHjFS5lUSU6JRWK=
EW-11 M3L1dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVLGSZFYUUN3ME2xNU42OTh4IN88US=> NGnYfFNUSU6JRWK=
SK-MM-2 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTFzLkiwOlEh|ryP NYT5b3o4W0GQR1XS
NCI-H524 NH\ZfldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYHJR|UxRTFzLkm4NlIh|ryP MWTTRW5ITVJ?
NOS-1 Mn\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGrYSWVKSzVyPUGyMlA{PDVizszN MWLTRW5ITVJ?
AM-38 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUnJR|UxRTF{LkW2N|Mh|ryP M3PPS3NCVkeHUh?=
A498 NYDPeJk2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoTLTWM2OD1zMj63NFY6KM7:TR?= MlHnV2FPT0WU
KARPAS-422 M2DYfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3rz[2lEPTB;MUKuO|Q6PiEQvF2= NHjzW29USU6JRWK=
LU-139 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1ntd2lEPTB;MUKuPVAzPiEQvF2= MVLTRW5ITVJ?
COR-L88 M{\FeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUPJRmw3UUN3ME2xNk46Ozh{IN88US=> NHf2UVVUSU6JRWK=
K5 MoX1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVnJR|UxRTF{Lkm0OlIh|ryP NUDHVFVmW0GQR1XS
NB13 MlLhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnfETWM2OD1zMj65O|g{KM7:TR?= NH33fYlUSU6JRWK=
MRK-nu-1 NUTYVno3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXyTWM2OD1zMz6xPVUh|ryP MmPaV2FPT0WU
MHH-NB-11 NYnsV29pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkjWTWM2OD1zMz6yPVAzKM7:TR?= MULTRW5ITVJ?
KU812 NUHGTnlyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUXDTWM6UUN3ME2xN{43OTJ2IN88US=> M2PUV3NCVkeHUh?=
TE-12 Mlf1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVHJR|UxRTF|Lk[5PVQh|ryP MVPTRW5ITVJ?
NCI-N87 MnOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3WyfmlEPTB;MUOuO|M3KM7:TR?= MkfIV2FPT0WU
EB2 M{TVTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4i0W2lEPTB;MUOuPFUxPSEQvF2= NY\zSlhKW0GQR1XS
DB MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFjzNo1KSzVyPUGzMlk5QDVizszN NUPQXWNpW0GQR1XS
697 MonOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVXJR|UxRTF2LkS1NVEh|ryP Ml\OV2FPT0WU
MSTO-211H NWDCdIJFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYLkdXZ1UUN3ME2xOE44PDR6IN88US=> M{nlXXNCVkeHUh?=
JVM-2 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHz3cIJKSzVyPUG0Mlc4OzVizszN NEXqTplUSU6JRWK=
COLO-824 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmHiTWM2OD1zND63PVk1KM7:TR?= NUPx[XgyW0GQR1XS
BC-3 MmjoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUK3dJZvUUN3ME2xOU4{QThizszN NVToVVBRW0GQR1XS
BOKU NXXTSpIyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXRTWM2OD1zNT65OlA5KM7:TR?= MUPTRW5ITVJ?
GOTO MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVTrWndVUUN3ME2xOk46PjF5IN88US=> NWD0UWcyW0GQR1XS
HCC2157 Mn\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYHJR|UxRTF5LkS3OVUh|ryP M2LsSXNCVkeHUh?=
LS-1034 NILPXGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXXIR5Q1UUN3ME2xO{43QDF6IN88US=> MoC1V2FPT0WU
CAL-148 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX;JR|UxRTF5Lkm3PVYh|ryP NXvrd4RWW0GQR1XS
MOLT-4 NFLVe2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmfjTWM2OD1zOD64NlA5KM7:TR?= M3XSUnNCVkeHUh?=
Daudi M4j2RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoTHTWM2OD1zOD65NlMyKM7:TR?= MVHTRW5ITVJ?
J-RT3-T3-5 MkCwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NU\SOYpPUUN3ME2xPU41ODZ4IN88US=> NWnXdmQ2W0GQR1XS
KMOE-2 M{nNZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYnJR|UxRTF7Lk[0PFIh|ryP NUXZb45SW0GQR1XS
HL-60 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXHGfJU{UUN3ME2yNE4yQTZ3IN88US=> MUPTRW5ITVJ?
P31-FUJ NFW1[GRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MknJTWM2OD1{MD60O|U{KM7:TR?= NHvKU4hUSU6JRWK=
IM-9 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUHJR|UxRTJyLk[yNlQh|ryP MULTRW5ITVJ?
HDLM-2 NIPxWmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV\ZbIN6UUN3ME2yNE45QDJzIN88US=> MV\TRW5ITVJ?
NCI-H1304 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIj0PFhKSzVyPUKxMlA{OTFizszN M1XoeXNCVkeHUh?=
NCI-H345 MkPOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnPlTWM2OD1{MT6wOlQ{KM7:TR?= MkfnV2FPT0WU
RPMI-6666 NXzsbmNuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlnkTWM2OD1{MT6zOlAzKM7:TR?= Mlf3V2FPT0WU
GR-ST MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFvqcXRKSzVyPUKxMlQyPyEQvF2= NHu1XXhUSU6JRWK=
CHP-126 NFvtWFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlPYTWM2OD1{MT62NVgyKM7:TR?= Ml7xV2FPT0WU
EHEB NIPVfItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVjJR|UxRTJzLk[3N|Eh|ryP M{LzOXNCVkeHUh?=
CPC-N M3XhR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWXJR|UxRTJ2LkCyNFEh|ryP NVy5TpFDW0GQR1XS
NB1 M4rLOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3:x[2lEPTB;MkSuOlk{QSEQvF2= NE\4bWNUSU6JRWK=
LS-123 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1GxVWlEPTB;MkSuPVAyOiEQvF2= M4fyTXNCVkeHUh?=
ST486 NFm0epVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlXyTWM2OD1{NT6xNVE{KM7:TR?= MV7TRW5ITVJ?
NCI-H1963 M4\X[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1jrUWlEPTB;Mk[uNFYzOyEQvF2= NY[1fHk3W0GQR1XS
U-87-MG M2nZbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn;vTWM2OD1{Nj63OlQ1KM7:TR?= NHT0dJZUSU6JRWK=
COR-L279 MofKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVnJR|UxRTJ4Lke5NlIh|ryP M3zHXnNCVkeHUh?=
LU-165 NUHzblVKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fHc2lEPTB;MkiuNFg3OSEQvF2= NVvSNpRFW0GQR1XS
COLO-800 NGXvR4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MULJR|UxRTJ6LkK5OVYh|ryP MXvTRW5ITVJ?
ETK-1 NHP4UmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWDJR|UxRTJ6LkO0OFYh|ryP MUXTRW5ITVJ?
LNCaP-Clone-FGC MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{fZXmlEPTB;MkmuPVI5OSEQvF2= NVK0dod5W0GQR1XS
SIG-M5 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{[4VGlEPTB;M{CuO|k2OiEQvF2= MU\TRW5ITVJ?
NB6 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGPTdHZKSzVyPUOwMlk2ODNizszN NIT6b|JUSU6JRWK=
NCI-H2107 NXThe4JxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVjxT45WUUN3ME2zNU4zOzN6IN88US=> NVnweY5EW0GQR1XS
SNU-C1 NXHP[ZI6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGrVUINKSzVyPUOxMlMyOjZizszN Mo\QV2FPT0WU
JAR Mmn4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV3JR|UxRTNzLkO3PVkh|ryP NI\lSHVUSU6JRWK=
L-363 NGnZe3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYTJR|UxRTN{LkKxOFQh|ryP NEHTWXJUSU6JRWK=
EW-24 M4nHbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NULRfnpTUUN3ME2zNk4{PDd2IN88US=> MoPjV2FPT0WU
NB69 M{S0bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWTaXGhSUUN3ME2zN{43PDV2IN88US=> M1nUXXNCVkeHUh?=
EW-13 NXPzTXdUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2\XR2lEPTB;M{OuPFk3QSEQvF2= NVi4dphGW0GQR1XS
Ramos-2G6-4C10 NGPuNW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkWwTWM2OD1|ND6yPVk{KM7:TR?= M2TISnNCVkeHUh?=
TE-11 M2e1[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVuye49IUUN3ME2zOE41QDJ{IN88US=> M{XhdXNCVkeHUh?=
L-428 NGfrdYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXnJR|UxRTN2Lke1N|Yh|ryP NGnXe|ZUSU6JRWK=
KP-N-YN NVLUdIt[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYSzeVBvUUN3ME2zOE46ODV5IN88US=> NGfQfJRUSU6JRWK=
CGTH-W-1 NWfzUm1RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEjrS5VKSzVyPUO2MlkxPDhizszN NVzxbmp5W0GQR1XS
K-562 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUjJR|UxRTN5LkC4OlQh|ryP M4rnRXNCVkeHUh?=
NCI-H1299 NFezdHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHn2PW9KSzVyPUO4MlE3ODNizszN NWrwZZE5W0GQR1XS
RCC10RGB NYjCRVU4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn3qTWM2OD1|OD6yNFg{KM7:TR?= M1nHPHNCVkeHUh?=
NCI-SNU-16 NGWyc5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4WzdWlEPTB;M{iuOVY2OyEQvF2= Mm[yV2FPT0WU
LC-2-ad M2Dj[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4\JfWlEPTB;M{muOFM{PyEQvF2= NYThUJV4W0GQR1XS
MHH-PREB-1 MnTtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmDPTWM2OD1|OT63N|g5KM7:TR?= M1\P[XNCVkeHUh?=
NCI-H64 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3vWWGlEPTB;NECuNFk1QCEQvF2= NUnQSFZnW0GQR1XS
LB996-RCC NH;2[WZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2CxWGlEPTB;NECuPFcyPiEQvF2= M2f1NnNCVkeHUh?=
DEL NFf1eIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGLid25KSzVyPUSxMlQ1ODVizszN M3HTPXNCVkeHUh?=
MLMA NGO2fJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3HzV2lEPTB;NEGuO|U6PSEQvF2= NGjaVoNUSU6JRWK=
SBC-1 NFHWc2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV;JR|UxRTR{LkG4NFYh|ryP MX7TRW5ITVJ?
MPP-89 NUX0PFZJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn3STWM2OD12Mj61PFc2KM7:TR?= NH[4XpVUSU6JRWK=
MV-4-11 M{POTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NULVW3FvUUN3ME20Nk46ODZ5IN88US=> MnG0V2FPT0WU
EoL-1- MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIX1foVKSzVyPUS0MlE2PjhizszN MX;TRW5ITVJ?
CW-2 NHLCZnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3HaO2lEPTB;NESuPFM1OiEQvF2= NIrveoVUSU6JRWK=
HT NXj3XZJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIfEb4xKSzVyPUS1MlcxODdizszN MWDTRW5ITVJ?
SW954 MnzrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkntTWM2OD12Nz60NVI5KM7:TR?= MXnTRW5ITVJ?
A3-KAW M3zM[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH\zRllKSzVyPUS5MlgxPjFizszN MYTTRW5ITVJ?
TC-YIK M4SzWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX;JR|UxRTVyLkCzOlMh|ryP MV;TRW5ITVJ?
SW962 MoTIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXSyNlR6UUN3ME21OE45OzV5IN88US=> MVrTRW5ITVJ?
KP-N-RT-BM-1 NVL4[FFUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXrJR|UxRTV4Lk[2N|gh|ryP MV7TRW5ITVJ?
NCI-H1395 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXH0[ZlVUUN3ME21PE45OTd{IN88US=> MXPTRW5ITVJ?
RPMI-8402 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWrzUVBlUUN3ME21PE46PTJ4IN88US=> MmPzV2FPT0WU
SCH M4fDdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NG[4S|hKSzVyPU[wMlk3OzhizszN NEXlXopUSU6JRWK=
NCI-H2196 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUixboN2UUN3ME22NU4zOzFizszN NI\qOIxUSU6JRWK=
LOXIMVI MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFHnT2NKSzVyPU[xMlgzPjZizszN M13CeHNCVkeHUh?=
TGBC24TKB MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkjrTWM2OD14Mj6xOFkyKM7:TR?= MUPTRW5ITVJ?
SK-MEL-2 NHHK[HlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnOwTWM2OD14Mz65PFkzKM7:TR?= Mn\GV2FPT0WU
U-698-M NUPhNpNnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml\WTWM2OD14OD61Olg4KM7:TR?= MX3TRW5ITVJ?
NCI-H1522 M{DRdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2fRWmlEPTB;NkmuNFA1PyEQvF2= MXXTRW5ITVJ?
UACC-812 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFHpSppKSzVyPU[5MlUzODlizszN NEXhXnhUSU6JRWK=
MHH-CALL-2 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYLJR|UxRTdyLkC2JO69VQ>? MojFV2FPT0WU
NB5 M1\6emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\vbZNKSzVyPUewMlM1PjhizszN NVHtPWxyW0GQR1XS
KARPAS-299 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV[4cGpvUUN3ME23NE41PDR5IN88US=> MmPlV2FPT0WU
NCI-H1694 M4fKSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXHJR|UxRTdzLkCzNkDPxE1? NWS0dJV2W0GQR1XS
NCI-H82 M4[zWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIXEb4ZKSzVyPUexMlk2ODdizszN M4jxenNCVkeHUh?=
SCC-15 MlzkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVPiZ4ZNUUN3ME23Nk4{PCEQvF2= NXX6[Y9KW0GQR1XS
NCI-H1436 NELGeZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn3MTWM2OD15Mj63OFU3KM7:TR?= NIfzcoNUSU6JRWK=
ATN-1 NVPvNoM6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUGxU5BiUUN3ME23OE42ODVizszN NE\h[IdUSU6JRWK=
RPMI-8866 NUDScG5bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIjv[WNKSzVyPUe0Mlc2ODlizszN NU\QUGxGW0GQR1XS
HCC1599 NXrtO|lLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmK3TWM2OD15ND64O|MzKM7:TR?= NIXC[4dUSU6JRWK=
NCI-H1155 NGKxNY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYjQZXY4UUN3ME23OE46OzZ5IN88US=> MlTaV2FPT0WU
DOHH-2 MnfIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIr5c2VKSzVyPUe0Mlk2OTRizszN NF:yc|RUSU6JRWK=
SK-NEP-1 NF3IO2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVHw[ow3UUN3ME23OU4xPzV2IN88US=> MWLTRW5ITVJ?
HCC1187 MlO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2nhVmlEPTB;N{euOlEzOiEQvF2= MUjTRW5ITVJ?
NCI-H322M NWDyfnJDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVHKZXhTUUN3ME23PE4{PzB7IN88US=> M2TZd3NCVkeHUh?=
NCI-H526 MoTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYjJR|UxRTd6LkW4O|ch|ryP Mn;zV2FPT0WU
NCI-H2171 M1TxWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEnOVINKSzVyPUe5MlQyOzZizszN NHTCfJdUSU6JRWK=
COLO-668 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHrK[IlKSzVyPUixMlU5QDRizszN M1mxT3NCVkeHUh?=
RS4-11 NGPh[VZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NILaXIpKSzVyPUiyMlI2ODVizszN MVjTRW5ITVJ?
NCI-H716 NYfuNpczT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEfvco1KSzVyPUiyMlkxPzVizszN MoPpV2FPT0WU
LU-134-A NHnPVXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3;BeWlEPTB;OEOuNVM2OSEQvF2= M4ThenNCVkeHUh?=
RPMI-8226 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3\VUGlEPTB;OESuNlExPyEQvF2= M2TPbXNCVkeHUh?=
KY821 NHztRlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWnrWnhtUUN3ME25NU43PTVzIN88US=> MkfBV2FPT0WU
ECC4 M3n5dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2\ycmlEPTB;OUOuPFI3QSEQvF2= M13Uc3NCVkeHUh?=
EW-3 NUT4dmQ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MknVTWM2OD17ND65NFgyKM7:TR?= MlSzV2FPT0WU
NB7 NEPyd5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEL3SllKSzVyPUm1Mlc4QDZizszN MnnjV2FPT0WU
NCI-H720 MkHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVjJR|UxRTl6LkSwOlEh|ryP MWHTRW5ITVJ?
NCI-H446 NWrUU3lmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWHQV3BiUUN3ME25PU44PTh6IN88US=> MVfTRW5ITVJ?
NCI-H889 NGL1R5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXTJR|UxRTFyND6yOFIh|ryP NWO0PZN7W0GQR1XS
EW-22 Mmm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{T4VWlEPTB;MUC2MlE6KM7:TR?= NE\rXI9USU6JRWK=
BV-173 NIfvXVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHfXfWFKSzVyPUGwPE44OjhizszN NU\6VZF2W0GQR1XS
WSU-NHL MmHTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlWwTWM2OD1zMEmuOlcyKM7:TR?= M4W5c3NCVkeHUh?=
MN-60 NYHQVXo{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn3xTWM2OD1zMEmuOlkh|ryP MlO5V2FPT0WU
DG-75 M3Xxdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWnJR|UxRTFzMz6zOVIh|ryP MmnIV2FPT0WU
DMS-79 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFyzcWRKSzVyPUGxO{4{QDJizszN NXPPZ25oW0GQR1XS
SK-MEL-1 Ml22S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGr5PVhKSzVyPUGxPE4xODlizszN M1nXb3NCVkeHUh?=
DMS-153 MoPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGDZVmlKSzVyPUGyNU44PDVizszN NX7s[FRsW0GQR1XS
NCI-H510A MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYHJR|UxRTF{Nz6zNkDPxE1? NGPoSI5USU6JRWK=
BE-13 NFXJUXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH6xOoxKSzVyPUGzOE4xPDRizszN M2PnZ3NCVkeHUh?=
KP-N-YS M4fV[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYDJR|UxRTF|OT63N|Yh|ryP M2C1XXNCVkeHUh?=
SUP-T1 MmD0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3ThOGlEPTB;MUSzMlcxQCEQvF2= NHjvcoRUSU6JRWK=
EW-12 MmjVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NES4XYdKSzVyPUG0OE43QTlizszN NYfETXBYW0GQR1XS
NB14 NHvLeYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkjnTWM2OD1zNEeuNFgzKM7:TR?= NGT2TmJUSU6JRWK=
MDA-MB-134-VI MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXXHdmM3UUN3ME2xOFgvOjZ6IN88US=> MljjV2FPT0WU
NCI-H1770 MmPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MljiTWM2OD1zNU[uNlc6KM7:TR?= M2m1RXNCVkeHUh?=
TUR NFTYXllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFqzbJFKSzVyPUG2O{45PyEQvF2= MY\TRW5ITVJ?
NCI-H1417 M17INGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NY[2cIhbUUN3ME2xPFAvOzNzIN88US=> Mon3V2FPT0WU
IMR-5 NXPOfWE6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYnJR|UxRTF6MT61O|Eh|ryP MkHPV2FPT0WU
NCI-H226 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGi1UJVKSzVyPUG4PE45PjZizszN M4q1enNCVkeHUh?=
NCI-H187 NXPt[m9KT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV3JR|UxRTF7MD6wOlQh|ryP M1KyNXNCVkeHUh?=
SF539 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1\K[WlEPTB;MUmyMlczQCEQvF2= Mk\QV2FPT0WU
TALL-1 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHz5[FhKSzVyPUG5PE4{ODRizszN MkjNV2FPT0WU
TE-441-T M3rrZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVrJR|UxRTF7OT63N|kh|ryP MWDTRW5ITVJ?
REH NFzhb5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlHlTWM2OD1{M{[uOlI3KM7:TR?= M4LocHNCVkeHUh?=
MS-1 NF:5[YVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF3kNYVKSzVyPUKzPU4yOjFizszN NFLnXIZUSU6JRWK=
THP-1 NITJPGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHLV[nVKSzVyPUK2OE44OzhizszN NEXiS2lUSU6JRWK=
NCI-H1838 NYfsSHN1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlTzTWM2OD1{N{GuOFU3KM7:TR?= NILpcJdUSU6JRWK=
P30-OHK NHLxRZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Moi5TWM2OD1{OEOuPFQ4KM7:TR?= NW\kWpZNW0GQR1XS
C8166 Mn3wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVzJR|UxRTN2NT6zN|gh|ryP M2rtT3NCVkeHUh?=

... Click to View More Cell Line Experimental Data

体内研究 MG-132给药有效恢复mdx小鼠骨骼肌纤维中肌萎缩蛋白,β-营养不良聚糖蛋白,α-营养不良聚糖蛋白,和α-肌聚糖蛋白的表达水平和血浆膜定位,减少肌肉膜损伤,并改善肌肉萎缩症的组织病理学信号。[7] MG-132治疗通过下调肌肉特异性泛素连接酶atrogin-1/MAFbx 和MuRF-1 mRNA,显著减少小鼠体内固定化诱导的骨骼肌萎缩。[8]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验:

[1]

+ 展开

MG-132对20S蛋白酶体抑制活性的测定:

20S蛋白酶体抑制试验的反应混合物包含0.1 M Tris-乙酸,pH 7.0,20S 蛋白酶体,MG-132,和25 μM底物,溶解于二甲基亚砜,终体积为1 mL。在37 °C下培养15分钟后,加入pH 9.0的0.1 mL 10% SDS 和0.9 mL 0.1M Tris 乙酸盐停止反应。测量反应产物的荧光。为测定对20S蛋白酶体的IC50,试验混合物中包含不同浓度的MG-132。
细胞实验:

[3]

+ 展开
  • Cell lines: KIM-2,HC11,和 ES
  • Concentrations: 溶解于DMSO,终浓度为~25 μM
  • Incubation Time: 24 和 48小时
  • Method:

    细胞在不同浓度的MG-132下暴露24,和48小时。上清液和单层细胞通过离心采集,并固定在含70%乙醇的PBS中,用吖啶橙着色。等体积细胞和吖啶橙(5 mg/mL的PBS溶液)在显微镜载玻片上固定,并通过荧光显微镜检测。对于膜联蛋白V分析,细胞通过离心采集,并用膜联蛋白V和碘化丙啶着色。对于细胞分析,细胞在PBS中于室温下再水化10分钟,随后用碘化丙啶(5 mg/mL)着色。所有样品使用Coulter Epics XL流式细胞分析仪分析。


    (Only for Reference)
动物实验:

[7]

+ 展开
  • Animal Models: 雄性 mdx (C57BL/10ScSn DMD mdx) 小鼠
  • Formulation: 在DMSO中溶解,并在PBS中稀释
  • Dosages: ~10 μg/kg/day
  • Administration: 注射
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 90 mg/mL (189.22 mM)
Ethanol 25 mg/mL (52.56 mM)
Water Insoluble
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
4% DMSO+30% PEG 300+20% propylene glycol+ddH2O
2mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 475.62
化学式

C26H41N3O5

CAS号 133407-82-6
稳定性 powder
in solvent
别名 N/A

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、MSDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、MSDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

常见问题及建议解决方法

  • 问题 1:

    I want to know whether it contains EDTA or other chelating agent in this product(S2619)?

  • 回答:

    Our S2619 MG-132 doesn't contain EDTA or other chelating agent.

Proteasome Signaling Pathway Map

Proteasome Inhibitors with Unique Features

相关Proteasome产品

Tags: 购买MG-132 | MG-132供应商 | 采购MG-132 | MG-132价格 | MG-132生产 | 订购MG-132 | MG-132代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID